3.4 News

May 30, 2020

Tempus Launches COVID-19-Specific Clinical and Research Initiatives for Oncology

Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, introduced a series of offerings designed to both advance vital research and support physicians in treating cancer patients, despite the challenges of the COVID-19 pandemic. Tempus is equipping physicians with the tools...

May 29, 2020

Tempus TIME Trial™ Program Reaches Critical Scale and Operational Milestones

Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, has reached a milestone in fully enrolling 2,500 oncologists into its Tempus Integrated Molecular Evaluation (TIME) Trial™ Program that seeks to rapidly match patients largely in the community setting to targeted clinical trials....

May 15, 2020

Tempus Announces Expansion Into Infectious Diseases, Starting with COVID-19

Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, today announced its expansion into infectious diseases, starting with COVID-19. Tempus is leveraging its existing capabilities to launch a diagnostic polymerase chain reaction (PCR) test, as well as a broad-based, healthcare operations...

April 21, 2020

Tempus Announces Prospective Psychiatric Study

Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, today announced its new prospective, pharmacogenomics study in psychiatry. The observational study aims to demonstrate the need for more transparent and reliable access to public data specific to a patient’s pharmacogenetic...

April 16, 2020

Milken Institute COVID-19 Interview with Eric Lefkofsky

https://milkeninstitute.org/podcast/conversations-mike-milken-eric-lefkofsky

March 16, 2020

Tempus Announces the Addition of Dr. Kimberly Blackwell as Chief Medical Officer and Dr. Kenneth Carson as Vice President of Clinical Solutions

Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, announces the addition of Kimberly Blackwell, M.D., as Chief Medical Officer and Kenneth Carson, M.D., as Vice President of Clinical Solutions. “Our platform is designed to help clinicians make real-time, dat...

March 13, 2020

Tempus Announces $100 Million in Series G Financing

Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, today announced an additional $100 million financing at a post-money valuation of $5 billion dollars. The investors include Baillie Gifford, Franklin Templeton, NEA, Novo Holdings, and funds and accounts managed by T. Rowe Price. The...

February 3, 2020

New Genomics Technology Puts Precision Oncology into Practice at Rush

Rush University Medical Center is the first health care organization to launch medical record company Epic’s module for genomic results, giving providers the tools they need to tailor patient care at the molecular level. Rush will use the module as part of its Precision Oncology Center to...

January 20, 2020

Tempus Unveils AI-Enabled Smart Tests Across Disease Types

Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, unveils its AI-enabled laboratory test (smart test) platform. Through its technology, laboratory tests are now able to be embedded with real-world evidence that deliver real-time, actionable insights to physicians, providing critical information...

January 15, 2020

Tempus Announces the Addition of Ari Caroline and Iker Huerga To Its Leadership Team

Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, announces the appointment of Ari Caroline and Iker Huerga as the Senior Vice President of Health Strategy and Vice President of Data Engineering and Strategy, respectively. Caroline and Huerga have joined Tempus as...

Show More